| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
23,799 |
20,860 |
$1.72M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,855 |
5,850 |
$527K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,162 |
3,161 |
$210K |
| 99215 |
Prolong outpt/office vis |
1,259 |
1,225 |
$114K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,906 |
3,715 |
$94K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,695 |
5,380 |
$34K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,098 |
2,914 |
$21K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
517 |
509 |
$5K |
| 81025 |
|
548 |
537 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,643 |
1,553 |
$3K |
| 81003 |
|
2,050 |
2,006 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
244 |
137 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13 |
12 |
$597.60 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
118 |
111 |
$419.54 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
96 |
96 |
$313.00 |
| 99051 |
|
16,758 |
15,226 |
$273.32 |
| 73130 |
|
13 |
13 |
$215.90 |
| 82962 |
|
65 |
65 |
$135.53 |
| 87400 |
|
24 |
12 |
$117.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
15 |
14 |
$74.25 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
82 |
80 |
$30.89 |
| A4570 |
Splint |
265 |
261 |
$20.00 |
| 99072 |
|
1,799 |
1,657 |
$17.50 |
| 3074F |
|
10,731 |
9,685 |
$15.55 |
| 2000F |
|
16,438 |
14,650 |
$14.03 |
| 3078F |
|
7,962 |
7,271 |
$12.19 |
| 3079F |
|
5,974 |
5,579 |
$7.84 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
32 |
31 |
$6.73 |
| 3077F |
|
2,787 |
2,574 |
$4.24 |
| 3075F |
|
2,559 |
2,444 |
$3.88 |
| 3080F |
|
2,326 |
2,155 |
$3.64 |
| 3008F |
|
9,037 |
8,266 |
$0.11 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
7,657 |
6,780 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
13 |
13 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
405 |
365 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
5,938 |
5,306 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
31 |
31 |
$0.00 |
| G8432 |
Depression screening not documented, reason not given |
5,955 |
5,252 |
$0.00 |
| 99070 |
|
13 |
13 |
$0.00 |